Insecticides (India) Limited

As of June 30, 2026, Insecticides (India) Limited carries a market capitalization of 19.23B, placing it among publicly traded companies globally. Its enterprise value stands at 19.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Insecticides (India) Limited's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Insecticides (India) Limited has 29.10M shares outstanding.

As of June 30, 2026, Insecticides (India) Limited trades at a trailing price-to-earnings ratio of 15.37.

As of June 30, 2026, Insecticides (India) Limited trades at an EV/EBITDA multiple of 9.15 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.93 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.17 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 19.23B versus a market cap of 19.23B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 7.75M in revenue per employee across its workforce of 2,658.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Insecticides (India) Limited recorded 428.66M in income tax expense. That works out to an effective tax rate of 25.51, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.68B, leaving 1.25B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Insecticides (India) Limited's stock has declined approximately 26.04% over the past 52 weeks. The 50-day moving average sits at 596.62, while the 200-day moving average is 641.99.

Over the twelve months ended June 30, 2026, Insecticides (India) Limited generated 20.60B in revenue and converted that into 1.25B in net income, yielding earnings per share of 42.99. EBITDA reached 2.10B, while operating income came in at 1.72B.

Over the twelve months ended June 30, 2026, Insecticides (India) Limited posted a gross margin of 32.35, reflecting its pricing power and cost economics. The operating margin of 8.36 and net profit margin of 6.08 provide insight into operational efficiency.

Insecticides (India) Limited's most recent stock split took place on September 30, 2022 with a 2:3 split ratio.